We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
BIP
126
Brandes Investment Partners
California
$182M -$7.43M -236,269 -4%
Stifel Financial
127
Stifel Financial
Missouri
$180M +$8.55M +271,661 +5%
LBA
128
Letko, Brosseau & Associates
Quebec, Canada
$179M -$8.42M -267,505 -4%
RJA
129
Raymond James & Associates
Florida
$178M +$21.2M +673,919 +13%
Chevy Chase Trust
130
Chevy Chase Trust
Maryland
$175M +$935K +29,707 +0.5%
AIM
131
Assured Investment Management
New York
$169M +$173M +5,499,425 +47,709%
Marshall Wace
132
Marshall Wace
United Kingdom
$159M +$58.8M +1,868,424 +56%
TG
133
TCW Group
California
$157M -$12.4M -393,318 -7%
1832 Asset Management
134
1832 Asset Management
Ontario, Canada
$155M +$112M +3,559,106 +253%
Two Sigma Advisers
135
Two Sigma Advisers
New York
$153M +$135M +4,292,155 +603%
Aviva
136
Aviva
United Kingdom
$152M +$17.6M +559,787 +13%
SH
137
Svenska Handelsbanken
Sweden
$150M +$154M +4,901,872 New
SBAM
138
Santa Barbara Asset Management
California
$149M +$3.31M +105,115 +2%
T
139
Thomaspartners
Massachusetts
$149M +$4.54M +144,205 +3%
AT
140
Alliance Trust
United Kingdom
$147M -$3.07M -97,706 -2%
Ohio Public Employees Retirement System (OPERS)
141
Ohio Public Employees Retirement System (OPERS)
Ohio
$146M -$2.35M -74,548 -2%
Korea Investment Corp
142
Korea Investment Corp
South Korea
$144M +$16.6M +526,157 +13%
KeyBank National Association
143
KeyBank National Association
Ohio
$144M -$2.79M -88,592 -2%
Thrivent Financial for Lutherans
144
Thrivent Financial for Lutherans
Minnesota
$143M +$8.98M +285,519 +7%
Retirement Systems of Alabama
145
Retirement Systems of Alabama
Alabama
$143M -$19M -603,504 -11%
GE
146
General Electric
Ohio
$142M -$73.9M -2,350,277 -34%
SO
147
STRS Ohio
Ohio
$139M +$1.46M +46,481 +1%
NFA
148
Nationwide Fund Advisors
Ohio
$138M -$38.6M -1,227,160 -21%
GIA
149
Gateway Investment Advisers
Ohio
$136M +$742K +23,599 +0.5%
Skandinaviska Enskilda Banken (SEB)
150
Skandinaviska Enskilda Banken (SEB)
Sweden
$135M +$139M +4,405,694 New

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.